Cell-free fetal DNA in maternal plasma: An important advance to link fetal genetics to obstetric ultrasound

Ultrasound in Obstetrics and Gynecology

Volumn 25, Issue 4, 2005, Pages 317-322

  Illanes, S ^a,b   Avent, N ^a,b   Soothill, P W ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; RHESUS D ANTIBODY;

APOPTOSIS; BLOOD GROUP TYPING; CELL FREE SYSTEM; DNA DETERMINATION; EDITORIAL; FETUS CIRCULATION; GENETIC DISORDER; GENETIC SCREENING; HUMAN; MATERNAL PLASMA; PHENOTYPE; POLYMERASE CHAIN REACTION; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SEX DETERMINATION; SINGLE NUCLEOTIDE POLYMORPHISM; ULTRASOUND; URINE;

EID: 17444366157     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1002/uog.1881     Document Type: Editorial

References (69)

1. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-487.
2. Lo YM, Tein MSC, Lau TK, Haines CJ, Leung TN, Poon PMK, Wainscoat JS, Johnson PJ, Chang AMZ, Hjelm NM. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998; 62: 768-775.
3. Ding C, Chiu RW, Lau TK, Leung TN, Chan LC, Chan AY, Charoenkwan P, Ng IS, Law HY, Ma ES, Xu X, Wanapirak C, Sanguansermsri T, Liao C, Ai MA, Chui DH, Cantor CR, Lo YM. MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. Proc Natl Acad Sci USA 2004; 101: 10762-10767.
4. Li Y, Zimmermann B, Rusterholz C, Kang A, Holzgreve W, Hahn S. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem 2004; 50: 1002-1011.
5. Chan KC, Zhang J, Hui AB, Wong N, Lau TK, Leung TN, Lo KW, Huang DW, Lo YM. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004; 50: 88-92.
6. Mann K, Donaghue C, Fox SP, Docherty Z, Ogilvie CM. Strategies for the rapid prenatal diagnosis of chromosome aneuploidy. Eur J Hum Genet 2004; 12: 907-915.
7. Slater HR, Bruno DL, Ren H, Pertile M, Scheuten JP, Choo KH. Rapid, high throughput prenatal detection of aneuploidy using a novel quantitative method (MLPA). J Med Genet 2003; 40: 907-912.
8. Benachi A, Yamgnane A, Olivi M, Dumez Y, Gautier E, Costa JM. Impact of formaldehyde on the in vitro proportion of fetal DNA in maternal plasma and serum. Clin Chem 2005; 51: 242-244.
9. Dhallan R, Au WC, Mattagajasingh S, Emche S, Bayliss P, Damewood M, Cronin M, Chou V, Mohr M. Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. JAMA 2004; 291: 1114-1119.
10. Wataganara T, Bianchi DW. Fetal cell-free nucleic acids in the maternal circulation: new clinical applications. Ann N Y Acad Sci 2004; 1022: 90-99.
11. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999; 64: 218-224.
12. Poon LL, Leung TN, Lau TK, Lo YM. Presence of fetal RNA in maternal plasma. Clin Chem 2000; 46: 1832-1834.
13. Ng EK, Tsui NB, Lau TK, Leung TN, Chiu RW, Panesar NS, Lit LC, Chan KW, Lo YM. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 2003; 100: 4748-4753.
14. Sekizawa A, Yokokawa K, Sugito Y, Iwasaki M, Yukimoto Y, Ichizuka K, Saito H, Okai T. Evaluation of bidirectional transfer of plasma DNA through placenta. Hum Genet 2003; 113: 307-310.
15. Bianchi DW. Fetal cells in the maternal circulation: feasibility for prenatal diagnosis. Br J Haematol 1999; 105: 574-583.
16. Bianchi DW. Circulating fetal DNA: its origin and diagnostic potential - a review. Placenta 2004; 25 (Suppl A): S93-S101.
17. Sekizawa A, Samura O, Zhen DK, Falco V, Farina A, Bianchi DW. Apoptosis in fetal nucleated erythrocytes circulating in maternal blood. Prenat Diagn 2000; 20: 886-889.
18. Hristoskova S, Holzgreve W, Hahn S. More than one-half of the erythroblasts in the fetal circulation and cord blood are TUNEL positive. Clin Chem 2001; 47: 1870-1871.
19. Soothill PW, Illanes S, Denbow M, Kailasam C, Finning K. Early detection of cell-free fetal DNA in maternal plasma. The British Society of Maternal and Fetal Medicine, 10th Annual Conference, April 2005; Abstract 95.
20. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1996; 93: 705-708.
21. Invernizzi P, Biondi ML, Battezzati PM, Perego F, Selmi C, Cecchini F, Podda M, Simoni G. Presence of fetal DNA in maternal plasma decades after pregnancy. Hum Genet 2002; 110: 587-591.
22. Johnson-Hopson CN, Artlett CM. Evidence against the long-term persistence of fetal DNA in maternal plasma after pregnancy. Hum Genet 2002; 111: 575.
23. Smid M, Galbiati S, Vassallo A, Gambini D, Ferrari A, Viora E, Pagliano M, Restagno G, Ferrari M, Cremonesi L. No evidence of fetal DNA persistence in maternal plasma after pregnancy. Hum Genet 2003; 112: 617-618.
24. Kolialexi A, Tsangaris GT, Antsaklis A, Mavroua A. Rapid clearance of fetal cells from maternal circulation after delivery. Ann N Y Acad Sci 2004; 1022: 113-118.
25. Benachi A, Steffann J, Gautier E, Ernault P, Olivi M, Dumez Y, Costa JM. Fetal DNA in maternal serum: does it persist after pregnancy? Hum Genet 2003; 113: 76-79.
26. Costa JM, Benachi A, Gautier E, Jouannic JM, Ernault P, Dumez Y. [First trimester fetal sex determination in maternal serum using real-time PCR.] [Article in French] Gynecol Obstet Fertil 2002; 30: 953-957.
27. Finning KM, Martin PG, Soothill PW, Avent ND. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002; 42: 1079-1085.
28. Botezatu I, Serdyuk O, Potapova G, Shelepov V, Alechina R, Molyaka Y, Ananev V, Bazin I, Garin A, Narimanov M, Knysh V, Melkonyan H, Umansky S, Lichtenstein A. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin Chem 2000; 46: 1078-1084.
29. Shi WJ, Sun YH, Cui LJ, Zhang Y, Li SR. [Detection of cell-free fetal DNA in the urine of pregnant women by nested polymerase chain reaction.] [Article in Chinese] Zhonghua Yi Xue Za Zhi 2003; 83: 482-484.
30. Al-Yatama MK, Mustafa AS, Ali S, Abraham S, Khan Z, Khaja N. Detection of Y chromosome-specific DNA in the plasma and urine of pregnant women using nested polymerase chain reaction. Prenat Diagn 2001; 21: 399-402.
31. Zhong XY, Hahn D, Troeger C, Klemm A, Stein G, Thomson P, Holzgreve W, Hahn S. Cell-free DNA in urine: a marker for kidney graft rejection, but not for prenatal diagnosis? Ann N Y Acad Sci 2001; 945: 250-257.
32. Li Y, Zhong XY, Kang A, Troeger C, Holzgreve W, Hahn S. Inability to detect cell free fetal DNA in the urine of normal pregnant women nor in those affected by pre-eclampsia associated HELLP syndrome. J Soc Gynecol Investig 2003; 10: 503-508.
33. Illanes S, Denbow M, Smith RP, Overton T, Finning K, Soothill PW. Detection of cell-free fetal DNA in maternal urine. The British Society of Maternal and Fetal Medicine, 10th Annual Conference, April 2005; Abstract 91.
34. Lo YM, Chiu RW. The biology and diagnostic applications of plasma RNA. Ann N Y Acad Sci 2004; 1022: 135-139.
35. Ng EK, Leung TN, Tsui NB, Lau TK, Panesar NS, Chiu RW, Lo YM. The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. Clin Chem 2003; 49: 727-731.
36. Farina A, Chan CW, Chiu RW, Tsui NB, Carinci P, Concu M, Banzola I, Rizzo N, Lo YM. Circulating corticotropin-releasing hormone mRNA in maternal plasma: relationship with gestational age and severity of preeclampsia. Clin Chem 2004; 50: 1851-1854.
37. Tsui NB, Chim SS, Chiu RW, Lau TK, Ng EK, Leung TN, Tong YK, Chan KC, Lo YM. Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling. J Med Genet 2004; 41: 461-467.
38. Jones ML, Wray J, Wight J, Chilcott J, Forman K, Tappenden P, Beverley C. A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant. BJOG 2004; 111: 892-902.
39. Cheong YC, Goodrick J, Kyle PM, Soothill P. Management of anti-Rhesus-D antibodies in pregnancy: a review from 1994 to 1998. Fetal Diagn Ther 2001; 16: 294-298.
40. National Institute for Clinical Excellence (NICE). Technology Appraisal Guidance 41: Guidance on the use of routine antenatal anti-D prophylaxis for RhD-negative women. NICE: London, 2002.
41. Daniels G, Finning K, Martin P, Soothill P. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn. Vox Sang 2004; 87: 225-232.
42. Avent ND, Finning KM, Martin PG, Soothill PW. Prenatal determination of fetal blood group status. Vox Sang 2000; 78 (Suppl 2): 155-162.
43. Nanal R, Kyle P, Soothill PW. A classification of pregnancy losses after invasive prenatal diagnostic procedures: an approach to allow comparison of units with a different case mix. Prenat Diagn 2003; 23: 488-492.
44. Tabor A, Bang J, Nørgaard-Pedersen B. Feto-maternal haemorrhage associated with genetic amniocentesis: results of a randomized trial. Br J Obstet Gynaecol 1987; 94: 528-534.
45. Murray JC, Karp LE, Williamson RA, Cheng EY, Luthy DA. Rh isoimmunization related to amniocentesis. Am J Med Genet 1983; 16: 527-534.
46. Lo YM. Fetal RhD genotyping from maternal plasma. Ann Med 1999; 31: 308-312.
47. Finning K, Martin P, Daniels G. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann N Y Acad Sci 2004; 1022: 119-123.
48. van der School CE, Tax GH, Rijnders RJ, de Haas M, Christiaens GC. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev 2003; 17: 31-44.
49. Rijnders RJ, van der School CE, Bossers B, de Vroede MA, Christiaens GC. Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol 2001; 98: 374-378.
50. Bartha JL, Finning K, Soothill PW. Fetal sex determination from maternal blood at 6 weeks of gestation when at risk for 21-hydroxylase deficiency. Obstet Gynecol 2003; 101: 1135-1136.
51. Costa JM, Benachi A, Gautier E. New strategy for prenatal diagnosis of X-linked disorders. N Engl J Med 2002; 9: 346: 1502.
52. Amicucci P, Gennarelli M, Novelli G, Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 2000; 46: 301-302.
53. Gonzalez-Gonzalez MC, Trujillo MJ, Rodriguez de Alba M, Ramos C. Early Huntington disease prenatal diagnosis by maternal semiquantitative fluorescent-PCR. Neurology 2003; 60: 1214-1215.
54. Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 2000; 30: 356: 1170.
55. Gonzalez-Gonzalez MC, Garcia-Hoyos M, Trujillo MJ, Rodriguez de Alba M, Lorda-Sanchez I, Diaz-Recasens J, Gallardo E, Ayuso C, Ramos C. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn 2002; 22: 946-948.
56. Chiu RW, Lau TK, Leung TN, Chow KC, Chui DH, Lo YM. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 2002; 360: 998-1000.
57. Oudejans CB, Go AT, Visser A, Mulders MA, Westerman BA, Blankenstein MA, van Vugt JM. Detection of chromosome 21-encoded mRNA of placental origin in maternal plasma. Clin Chem 2003; 49: 1445-1449.
58. Simpson JL, Bischoff F. Cell-free fetal DNA in maternal blood: evolving clinical applications. JAMA 2004; 291: 1135-1137.
59. Tjoa ML, Oudejans CB, van Vugt JM, Blankenstein MA, van Wijk IJ. Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction. Hypertens Pregnancy 2004; 23: 171-189.
60. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002; 186: 158-166.
61. Zhong XY, Laivuori H, Livingston JC, Ylikorkala O, Siabi BM, Olzgreve W, Hahn S. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia Am J Obstet Gynecol 2001; 184: 414-419.
62. Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, Haines CJ, Redman CW. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999; 45: 184-188.
63. Smid M, Vassallo A, Lagona F, Valsecchi L, Maniscalco L, Danti L, Lojacono A, Ferrari A, Ferrari M, Cremonesi L. Quantitative analysis of fetal DNA in maternal plasma in pathological conditions associated with placental abnormalities. Ann N Y Acad Sci 2001; 945: 132-137.
64. Leung TN, Zhang J, Lau TK, Chan LY, Lo YM. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 2001; 47: 137-139.
65. Cotter AM, Martin CM, O'leary JJ, Daly SF. Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia. Am J Obstet Gynecol 2004; 191: 515-520.
66. Levine RJ, Qian C, Leshane ES, Yu KF, England LJ, Schisterman EF, Wataganara T, Romero R, Bianchi DW. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004; 190: 707-713.
67. Caramelli E, Rizzo N, Concu M, Simonazzi G, Carinci P, Bondavalli C, Bovicelli L, Farina A. Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction - a pilot study. Prenat Diagn 2003; 23: 367-371.
68. Zhong XY, Wang Y, Chen S, Labu, Pubuzhuoma, Gesangzhuogab, Ouzhuwangmu, Hahn C, Holzgreve W, Hahn S. Can circulatory fetal DNA be used to study placentation at high altitude? Ann N Y Acad Sci 2004; 1022: 124-128.
69. Special Non-invasive Advances in Fetal and Neonatal Evaluation Network. Special advances in fetal evaluation. http://www2.warwick.ac.uk/fac/sci/bio/ safe/ [Accessed 25 January 2005].